Institutional Manager · CIK 0002006045
SymBiosis Capital Partners, LLC
BENTONVILLE, AR · File #028-26251
Latest AUM
$109.5M
Positions
11
Top-10 Concentration
100.0%
Filings
1
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | Evommune, Inc. | EVMN | +1,280,778 | +$21.9M | $0 |
| NEW | Verastem Inc | VSTM | +2,000,000 | +$15.4M | $0 |
| NEW | Aldeyra Therapeutics Inc | AMPGZ | +2,555,000 | +$13.2M | $0 |
| NEW | Precigen Inc | PGEN | +3,000,000 | +$12.5M | $0 |
| NEW | Inventiva S.A. | IVEVF | +2,600,000 | +$12.1M | $0 |
| NEW | Nuvation Bio Inc | NUVB | +1,250,000 | +$11.2M | $0 |
| NEW | Rani Therapeutics Holdings, Inc. | RANI | +6,300,000 | +$8.5M | $0 |
| NEW | Aardvark Therapeutics, Inc. | AARD | +476,595 | +$6.3M | $0 |
| NEW | Clene Nanomedicine Inc. | CLNN | +770,495 | +$4.5M | $0 |
| NEW | Generation Bio Co | 37148K209 | +665,000 | +$3.8M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202511 pos · $109.5M
Top 11 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Evommune, Inc. | EVMN | 1,280,778 | $21.9M | 20.03% |
| 2 | Verastem Inc | VSTM | 2,000,000 | $15.4M | 14.10% |
| 3 | Aldeyra Therapeutics Inc | AMPGZ | 2,555,000 | $13.2M | 12.09% |
| 4 | Precigen Inc | PGEN | 3,000,000 | $12.5M | 11.45% |
| 5 | Inventiva S.A. | IVEVF | 2,600,000 | $12.1M | 11.04% |
| 6 | Nuvation Bio Inc | NUVB | 1,250,000 | $11.2M | 10.23% |
| 7 | Rani Therapeutics Holdings, Inc. | RANI | 6,300,000 | $8.5M | 7.77% |
| 8 | Aardvark Therapeutics, Inc. | AARD | 476,595 | $6.3M | 5.71% |
| 9 | Clene Nanomedicine Inc. | CLNN | 770,495 | $4.5M | 4.13% |
| 10 | Generation Bio Co | 37148K209 | 665,000 | $3.8M | 3.45% |
| 11 | Surrozen, Inc. | SRZNW | 150,000 | $3,000 | 0.00% |